Anne-Kathrin Tausche

Summary

Country: Germany

Publications

  1. ncbi [Gout as a systemic disease. Manifestations, complications and comorbidities of hyperuricaemia]
    A K Tausche
    Medizinische Klinik und Poliklinik III, Abteilung Rheumatologie, Universitatsklinikum Carl Gustav Carus, Fetscherstr 74, 01307, Dresden, Deutschland
    Z Rheumatol 71:224-30. 2012
  2. ncbi The Janus faces of allopurinol-allopurinol hypersensitivity syndrome
    Anne-Kathrin Tausche
    Department of Internal Medicine, Section of Endocrinology and Rheumatology, University Hospital Carl Gustav Carus, Technical University of Dresden, Dresden, Germany
    Am J Med 121:e3-4. 2008
  3. ncbi Gout--current diagnosis and treatment
    Anne Kathrin Tausche
    Bereich Rheumatologie, Medizinische Klinik und Poliklinik III, Universitatsklinikum, Carl Gustav Carus an der TU Dresden, Dresden, Germany
    Dtsch Arztebl Int 106:549-55. 2009

Detail Information

Publications3

  1. ncbi [Gout as a systemic disease. Manifestations, complications and comorbidities of hyperuricaemia]
    A K Tausche
    Medizinische Klinik und Poliklinik III, Abteilung Rheumatologie, Universitatsklinikum Carl Gustav Carus, Fetscherstr 74, 01307, Dresden, Deutschland
    Z Rheumatol 71:224-30. 2012
    ..Gout is a complex metabolic and inflammatory disease and besides articular symptoms the renal and cardiovascular effects of hyperuricemia are particularly relevant for the overall prognosis...
  2. ncbi The Janus faces of allopurinol-allopurinol hypersensitivity syndrome
    Anne-Kathrin Tausche
    Department of Internal Medicine, Section of Endocrinology and Rheumatology, University Hospital Carl Gustav Carus, Technical University of Dresden, Dresden, Germany
    Am J Med 121:e3-4. 2008
  3. ncbi Gout--current diagnosis and treatment
    Anne Kathrin Tausche
    Bereich Rheumatologie, Medizinische Klinik und Poliklinik III, Universitatsklinikum, Carl Gustav Carus an der TU Dresden, Dresden, Germany
    Dtsch Arztebl Int 106:549-55. 2009
    ..In Germany, the prevalence of gouty arthritis is estimated at 1.4%, higher than that of rheumatoid arthritis. There are no German guidelines to date for the treatment of gout. Its current treatment is based largely on expert opinion...